Literature DB >> 7910018

Transfected human somatostatin receptor type 2, SSTR2, not only inhibits adenylate cyclase but also stimulates phospholipase C and Ca2+ mobilization.

H Tomura1, F Okajima, M Akbar, M Abdul Majid, K Sho, Y Kondo.   

Abstract

COS-7 cells were transfected with human somatostatin (SRIF) receptor type 1 and 2 (human SSTR1 and SSTR2, respectively) cDNAs. In human SSTR2-expressing cells, SRIF not only inhibited forskolin-induced cAMP accumulation but also stimulated phospholipase C and Ca2+ mobilization. While the inhibition of cAMP accumulation was completely reversed by pertussis toxin (PTX) treatment of the cells, SRIF-induced activation of phospholipase C and Ca2+ mobilization was partially but not completely inhibited by the toxin treatment. In human SSTR1-expressing cells, however, SRIF induced only slight inhibition of cAMP accumulation and stimulation of phospholipase C-Ca2+ system. We conclude that the transfected SSTR2 can couple to phospholipase C as well as adenylate cyclase in a stimulatory and inhibitory manner, respectively. Both PTX-sensitive and -insensitive GTP-binding proteins may be involved in the SSTR2 signal transduction mechanisms.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7910018     DOI: 10.1006/bbrc.1994.1547

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Comparison of functional profiles at human recombinant somatostatin sst2 receptor: simultaneous determination of intracellular Ca2+ and luciferase expression in CHO-K1 cells.

Authors:  Caroline Nunn; Davide Cervia; Daniel Langenegger; Laurent Tenaillon; Rochdi Bouhelal; Daniel Hoyer
Journal:  Br J Pharmacol       Date:  2004-03-22       Impact factor: 8.739

2.  Localization of the somatostatin receptor SST2A in rat brain using a specific anti-peptide antibody.

Authors:  P Dournaud; Y Z Gu; A Schonbrunn; J Mazella; G S Tannenbaum; A Beaudet
Journal:  J Neurosci       Date:  1996-07-15       Impact factor: 6.167

Review 3.  Somatostatin.

Authors:  T Reisine
Journal:  Cell Mol Neurobiol       Date:  1995-12       Impact factor: 5.046

4.  Somatostatin-induced control of cytosolic free calcium in pituitary tumour cells.

Authors:  C Petrucci; D Cervia; M Buzzi; C Biondi; P Bagnoli
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

5.  Somatostatin receptor type 2 contributes to the self-renewal of murine embryonic stem cells.

Authors:  Xin-xiu Xu; Li-hong Zhang; Xin Xie
Journal:  Acta Pharmacol Sin       Date:  2014-07-07       Impact factor: 6.150

6.  Co-incident signalling between mu-opioid and M3 muscarinic receptors at the level of Ca2+ release from intracellular stores: lack of evidence for Ins(1,4,5)P3 receptor sensitization.

Authors:  Damien S K Samways; Wen-hong Li; Stuart J Conway; Andrew B Holmes; Martin D Bootman; Graeme Henderson
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

Review 7.  Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 1--molecular pathways.

Authors:  Mehtap Cakir; Dorota Dworakowska; Ashley Grossman
Journal:  J Cell Mol Med       Date:  2010-11       Impact factor: 5.310

Review 8.  Somatostatin Receptors and Analogs in Pheochromocytoma and Paraganglioma: Old Players in a New Precision Medicine World.

Authors:  Mayank Patel; Isabel Tena; Abhishek Jha; David Taieb; Karel Pacak
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-29       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.